TY  - CHAP
M1  - Book, Section
TI  - Chapter 43. Nonalcoholic Fatty Liver Disease
A1  - Cohen, David E.
A1  - Anania, Frank A.
A2  - Greenberger, Norton J.
A2  - Blumberg, Richard S.
A2  - Burakoff, Robert
PY  - 2012
T2  - CURRENT Diagnosis & Treatment: Gastroenterology, Hepatology, & Endoscopy, 2e
AB  - Nonalcoholic  fatty  liver  disease  (NAFLD)  is  an  overarching  concept  that  includes  simple  steatosis  and  nonalcoholic  steatohepatitis  (NASH).NAFLD  is  commonly  associated  with  the  metabolic  syndrome,  obesity,  diabetes,  and  hyperlipidemia;  80%  of  patients  with  the  metabolic  syndrome  have  NAFLD.Patients  generally  present  without  clinical  symptoms  but  with  mild  transaminase  elevations;  NAFLD  is  the  most  common  cause  of  increased  serum  transaminase  levels.NAFLD  is  a  clinical  diagnosis  after  exclusion  of  other  causes  of  liver  disease.Ultrasound,  computed  tomography,  and  magnetic  resonance  imaging  are  useful  for  the  detection.Liver  biopsy  is  currently  required  to  distinguish  NASH  from  NAFLD.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/25
UR  - accessmedicine.mhmedical.com/content.aspx?aid=55961163
ER  -